OVERVIEW

Managing the Hematopoietic Cell Transplant Patient is organized by American Society for Parenteral and Enteral Nutrition (ASPEN) and will be held on Nov 02, 2021.

Accreditation:
CE Credits: 1.5 hours

Description:
This webinar will highlight nutrition assessment components, review nutrition support practices, and describe nutritional implications associated with gastrointestinal GVHD in hematopoietic cell transplantation (HCT) recipients. Patients undergoing HCT are a highly heterogenous population in terms of their nutrient needs and requirement for nutrition intervention. The implications of dose-intensive conditioning regimens, coupled with the debilitating effects of graft-versus-host disease (GVHD), can be extremely complex and adversely effect a patient's nutritional status. Decreased oral intake, increased nutrient requirements, and impaired nutrient utilization often necessitate medical nutrition therapy. The use of standard supportive care measures, including parenteral nutrition and enteral nutrition, have varied over the past four decades and are highly dependent upon the type of transplant being utilized.

Learning Objectives:
• Identify necessary components of a comprehensive nutritional assessment for patients undergoing hematopoietic cell transplantation
• Construct appropriate nutritional plan of care for patients undergoing hematopoietic cell transplantation 
• Describe nutritional implications associated with gastrointestinal graft versus host disease

KEY DATES

Event Start Date
02 Nov, 2021
Event Start Date
Event End Date
02 Nov, 2021
Event End Date
Credits
  • 1.5 CE Credits
  • TARGET AUDIENCE

    Physician

    SPECIALITIES

    HematologyTransplant Surgery

    RELATED CONFERENCES & LIVE WEBINARS

    May 16, 2022 - Nov 30, 2026 | Webcast

    State required course for Connecticut
    37 AMA PRA Category 1 Credits™
    ...
    More actions
    US$634.50

    May 16, 2022 - Nov 30, 2026 | Webcast

    State required course for Oklahoma
    32 AMA PRA Category 1 Credits™
    ...
    More actions
    US$534.50